Our Leadership | CSL Behring Medical Affairs
Meet the Leadership Team. Our dedicated employees drive our performance by delivering life-saving and life-improving therapies with an unwavering focus on helping many thousands of people live full lives.
Welcome to CSL Behring Medical Expert Portal
As a member of the CSL Behring Medical Expert Portal you will get access to up-to-date medical content, including live webinars, expert views, congress symposia replays and webinars on-demand, science updates, patient cases and patient support materials.
Medical Information | CSL Behring Medical Affairs
Medical Information. Product Temperature Stability Calculator. This tool provides product-specific information based on a single exposure to the temperature provided. CSL Behring recommends the use of its products only as described in the Prescribing Information. Select a Product.
These highlights do not include all the information needed to use HEMGENIX safely and effectively. See full prescribing information for HEMGENIX. HEMGENIX® (etranacogene dezaparvovec-drlb) suspension, for intravenous infusion Initial U.S. Approval: 2022.
Diseases & Conditions | CSL Behring Medical Affairs
Discover scientific information and resources for healthcare professionals related to CSL Behring medicines.
Hemophilia B| CSL Behring Medical Affairs
CSL Behring has over 40 years of experience in the field of hematology. Discover more information on hemophilia A and B, gene therapy in hemophilia, VKA-related bleeding, VWD, fibrinogen deficiency, and Factor XIII deficiency.
ZEMAIRA® | CSL Behring Medical Affairs
Discover more information on Zemaira ( Alpha1-Proteinase Inhibitor [Human]) for the augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema .
Allergy & Immunology | CSL Behring Medical Affairs
Select a CSL Behring Allergy and Immunology Product to learn more. CSL Behring has over 40 years of experience in the field of HAE. Discover more information on Hereditary Angioedema and Primary Immunodeficiency.
Hematology | CSL Behring Medical Affairs
CSL Behring has over 40 years of experience in the field of hematology. Discover more information on hemophilia A and B, gene therapy in hemophilia, VKA-related bleeding, VWD, fibrinogen deficiency, and Factor XIII deficiency.
IDELVION® | CSL Behring Medical Affairs
IDELVION®, Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rIX-FP), a recombinant DNA-derived coagulation Factor IX concentrate, is indicated in children and adults with Hemophilia B (congenital Factor IX deficiency) for on-demand treatment and control of bleeding episodes, perioperative management of bleeding and routine ...